CN Patent

CN117982682A — 用于治疗病毒感染的包含rna聚合酶抑制剂和环糊精的组合物

Assigned to Gilead Sciences Inc · Expires 2024-05-07 · 2y expired

What this patent protects

本发明提供了一种组合物，其包含化合物1或其药学上可接受的盐，环糊精，以及任选的pH调节剂。

USPTO Abstract

本发明提供了一种组合物，其包含化合物1或其药学上可接受的盐，环糊精，以及任选的pH调节剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN117982682A
Jurisdiction
CN
Classification
—
Expires
2024-05-07
Drug substance claim
No
Drug product claim
No
Assignee
Gilead Sciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.